-
Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm
-
Mitochondrial complex I and III gene mRNA levels in schizophrenia, and their relationship with clinical features
-
The Global Burden of Schizophrenia: Findings from the 2021 Global Burden of Diseases, Injuries, and Risk Factors Study
-
Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross‐Sectional Study
-
Affective Reactivity to a Single Bout of High-Intensity Interval Training in Schizophrenia: A Randomized Controlled Trial
-
An excitement building in the development of psychological treatments for schizophrenia
-
The new German evidence‐ and consensus‐based schizophrenia guideline
-
What does it take to make real‐world changes in schizophrenia care?
-
Towards an integrative and personalized care across the stages of schizophrenia spectrum disorders
-
Interventions in schizophrenia should be transdiagnostic, biologically informed, individualized, and disease modifying
-
Biomarkers in Schizophrenia: Current Approaches and New Developments—A Literature Review
-
Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations
-
Hydrogen Gas Therapy in Schizophrenia: Potential Neuroprotective Effects From an Animal Study
-
Insights into the origin of DNA methylation differences between monozygotic twins discordant for schizophrenia
-
Empowering Patients, Preventing Strokes: Knowledge of Risk Factors and Associated Factors, Prevention Strategies, and Treatment Awareness Among Chronic Disease Patients in Southern Ethiopia
-
Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report
-
Quality of Life After Psychosis: Surviving Schizophrenia and Making a Full Emotional Recovery
-
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case Report
-
A Systematic Review of the Magnetic Resonance Imaging Literature Investigating the Deficit Syndrome in Schizophrenia
-
Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging
-
Pilot Study of Behavioral Activation Treatment for Negative Symptoms in Older Adults With Schizophrenia Spectrum Disorder
-
Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
-
Moving on from the illusion of prevention towards effective prevention of psychosis
-
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study
